Jenny van Winkle, MD
Obstetrics & Gynecology · Clyde, NCNPI 1720218845
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $71,500 of the $94,331 with a category attached, or 75.8%. Applied Medical Resources Corporation accounts for 98.4% of it on its own, with 17 other manufacturers making up the rest. Among obstetrics & gynecology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 182 payments — averaging $518.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$93K
- Coloplast$568
- AbbVie$202
- Astellas Pharma US Inc$155
- Pfizer$123
- Bayer$96
- plus $371 from 12 others
What the payments were for
- Consulting fees$9131%
- Speaking & faculty fees$71,50076%
- Travel & lodging$17,70119%
- Food & beverage$4,0274%
- Education$1910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 132 | $92,816 |
| Coloplast | 6 | $568 |
| AbbVie | 13 | $202 |
| Astellas Pharma US Inc | 4 | $155 |
| Pfizer | 6 | $123 |
| Bayer | 3 | $96 |
| Amgen | 5 | $91 |
| Medtronic | 1 | $62 |
| Exact Sciences | 2 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Dexcom, Inc. | 1 | $25 |
| Exeltis, USA Inc. | 1 | $22 |
| Biogen | 1 | $20 |
| Novo Nordisk | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Myovant Sciences Inc. | 1 | $16 |
| Organon | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GelPOINT V-Path$86,561
- ALTIS$353
How this compares
$94,331 in reported general payments places this provider in the 95th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VeozahFezolinetant | 17 | $10,856 |
| Estradiol | 79 | $4,565 |
| PremarinEstrogens, Conjugated | 11 | $2,591 |
| ProgesteroneProgesterone, Micronized | 40 | $1,580 |
| Clobetasol Propionate | 20 | $879 |
| Estradiol (Twice Weekly)Estradiol | 11 | $489 |
| Nystatin | 17 | $232 |
| Fluconazole | 14 | $113 |
| Metronidazole | 12 | $50 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncVeozah | $155 | $10,85617 claims |
| PfizerPremarin | $123 | $2,59111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
Other obstetrics & gynecology in Clyde
- Robin MatthewsClyde$217K
- Jerry MatkinsCharlotte$481K
- Laura McKainWilmington$475K
- Leslie Hansen-LindnerCharlotte$372K
- Haywood BrownDurham$165K
- Jack IngeRaleigh$157K
- Geeta SwamyDurham$142K
- Karie LafleurAsheville$135K
- Ty RobinsonHigh Point$114K
- Shan BiscetteCharlotte$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.